Literature DB >> 28711609

The epigenetic landscape of differentiated thyroid cancer.

Sylvia L Asa1, Shereen Ezzat2.   

Abstract

Differentiated thyroid carcinoma of follicular cell-derivation is the most common endocrine neoplasm with a rapidly increasing incidence. The majority represent papillary carcinomas; more rarely, they are follicular carcinomas. The vast majority have indolent behavior, however a significant proportion progress to develop lymph node metastases and a smaller proportion disseminate systemically. While common and frequent genetic events have been described to underlie the development of these neoplasms, the factors contributing to differing behaviors among tumors with similar genetic alterations remain unclear. This review focuses on epigenetic mechanisms targeting major signaling pathways that underlie the spectrum of biological behaviors and that may have potential diagnostic, prognostic and therapeutic value.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarkers; Epigenetics; Follicular thyroid carcinoma; Papillary thyroid carcinoma; Thyroid tumors

Mesh:

Substances:

Year:  2017        PMID: 28711609     DOI: 10.1016/j.mce.2017.07.012

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  9 in total

1.  Study of Essential and Toxic Metal Imbalances in the Scalp Hair of Thyroid Cancer Patients in Comparison with Healthy Donors.

Authors:  Kalsoom Bibi; Munir H Shah
Journal:  Biol Trace Elem Res       Date:  2020-05-14       Impact factor: 3.738

2.  Overexpression of Histone H3 Lysine 27 Trimethylation Is Associated with Aggressiveness and Dedifferentiation of Thyroid Cancer.

Authors:  Chia-Chi Tsai; Ming-Nan Chien; Yuan-Ching Chang; Jie-Jen Lee; Shuen-Han Dai; Shih-Ping Cheng
Journal:  Endocr Pathol       Date:  2019-12       Impact factor: 3.943

3.  Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells.

Authors:  Valentina Maggisano; Marilena Celano; Saverio Massimo Lepore; Marialuisa Sponziello; Francesca Rosignolo; Valeria Pecce; Antonella Verrienti; Federica Baldan; Catia Mio; Lorenzo Allegri; Marianna Maranghi; Rosa Falcone; Giuseppe Damante; Diego Russo; Stefania Bulotta
Journal:  Endocrine       Date:  2019-01-19       Impact factor: 3.633

Review 4.  Immunohistochemical Biomarkers in Thyroid Pathology.

Authors:  Zubair Baloch; Ozgur Mete; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

Review 5.  Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer.

Authors:  Adelaide Greco; Luigi Auletta; Francesca Maria Orlandella; Paola Lucia Chiara Iervolino; Michele Klain; Giuliana Salvatore; Marcello Mancini
Journal:  Int J Mol Sci       Date:  2017-12-16       Impact factor: 5.923

Review 6.  Epigenetic Modifications: Novel Therapeutic Approach for Thyroid Cancer.

Authors:  Xuguang Zhu; Sheue Yann Cheng
Journal:  Endocrinol Metab (Seoul)       Date:  2017-09

Review 7.  Emerging Biomarkers in Thyroid Practice and Research.

Authors:  Shipra Agarwal; Andrey Bychkov; Chan-Kwon Jung
Journal:  Cancers (Basel)       Date:  2021-12-31       Impact factor: 6.639

Review 8.  Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis.

Authors:  Veronica Veschi; Francesco Verona; Melania Lo Iacono; Caterina D'Accardo; Gaetana Porcelli; Alice Turdo; Miriam Gaggianesi; Stefano Forte; Dario Giuffrida; Lorenzo Memeo; Matilde Todaro
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-25       Impact factor: 5.555

9.  The Prognostic Value of MicroRNAs in Thyroid Cancers-A Systematic Review and Meta-Analysis.

Authors:  Cristina Alina Silaghi; Vera Lozovanu; Horatiu Silaghi; Raluca Diana Georgescu; Cristina Pop; Anca Dobrean; Carmen Emanuela Georgescu
Journal:  Cancers (Basel)       Date:  2020-09-12       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.